VRP.L Regulatory News (VRP)

VRP.L Information

There is currently no data for VRP

REMOVE ADS

Director Shareholding

15 Oct 2012 14:01

Director Shareholding

15 October 2012 - London, UK - Verona Pharma plc (AIM: VRP.L) (the "Company") has received notification that on 12 October 2012, Jan-Anders Karlsson, CEO and a director of the Company, acquired an interest in 150,000 ordinary shares of 0.1p each in the Company ("Ordinary Shares") at a price of 4.5 pence per share.

Following the acquisition, Dr. Karlsson will have an interest in the Company of 150,000 Ordinary Shares, representing 0.05% of the Company's issued ordinary share capital.

-Ends-

For more information please contact:

Verona Pharma plc Tel: 020 7863 3300 Jan-Anders Karlsson, CEO info@veronapharma.com WH Ireland Group Plc Tel: 020 7220 1650 Chris Fielding Chris.fielding@WH-Ireland.Co.UK

XLON

Date		Source	Headline
13th Sep 2016	7:00 am	PRN	Half-year Report
12th Sep 2016	7:00 am	PRN	Appointment of Vikas Sinha as Non-Executive Director
30th Aug 2016	7:00 am	PRN	Data on RPL554 to be presented at ERS Congress
10th Aug 2016	9:59 am	PRN	Notice of Results
9th Aug 2016	2:16 pm	RNS	Director Dealing
5th Aug 2016	9:27 am	RNS	Holding(s) in Company
4th Aug 2016	3:26 pm	PRN	Grant of Share Options
4th Aug 2016	8:45 am	RNS	Holding(s) in Company
3rd Aug 2016	9:03 am	RNS	Holding(s) in Company
3rd Aug 2016	8:43 am	RNS	Holding(s) in Company
3rd Aug 2016	8:37 am	RNS	Holding(s) in Company
2nd Aug 2016	4:26 pm	RNS	Holding(s) in Company - Replacement
2nd Aug 2016	11:26 am	RNS	Holding(s) in Company
1st Aug 2016	3:57 pm	RNS	Holding(s) in Company
1st Aug 2016	11:40 am	RNS	Holding(s) in Company
1st Aug 2016	11:20 am	RNS	Holding(s) in Company
29th Jul 2016	8:06 am	PRN	Admission of Placing Shares
22nd Jul 2016	11:32 am	PRN	Result of GM
1st Jul 2016	8:00 am	PRN	Notice of GM
27th Jun 2016	1:42 pm	PRN	Result of AGM
20th Jun 2016	7:00 am	PRN	Proposed Placing and Notice of General Meeting
17th Jun 2016	4:54 pm	PRN	Proposed Placing and Notice of General Meeting
3rd Jun 2016	5:26 pm	PRN	2015 Annual Report and Accounts, Notice of AGM
3rd Jun 2016	7:00 am	PRN	Final Results
27th May 2016	2:48 pm	PRN	Notice of Results
10th May 2016	7:00 am	PRN	Add-on Phase II RPL554 study
4th May 2016	7:00 am	PRN	Verona to present RPL554 at the ATS Conference
19th Apr 2016	3:16 pm	PRN	Change of Registered Office
15th Apr 2016	4:08 pm	RNS	Holding(s) in Company
21st Mar 2016	7:00 am	PRN	Verona Pharma: 2015 in review
15th Mar 2016	7:00 am	PRN	Positive results from RPL554 dose-finding study
10th Feb 2016	2:47 pm	PRN	Grant of Share Options
21st Jan 2016	12:24 pm	RNS	Director Dealing
11th Jan 2016	7:00 am	PRN	Directorate Change
3rd Dec 2015	4:02 pm	PRN	Director Dealing
1st Dec 2015	5:11 pm	RNS	Holding(s) in Company
11th Nov 2015	7:00 am	PRN	RPL554 paper published in American Journal of Physiology
5th Nov 2015	7:00 am	PRN	Patient enrolment completed in RPL554 PhIIa studies
14th Oct 2015	7:00 am	PRN	Start of RPL554 Phase IIa combination study
8th Oct 2015	11:30 am	PRN	RPL554 data presented at North American CF Conference
29th Sep 2015	7:00 am	PRN	Positive headline data from RPL554 study
8th Sep 2015	7:00 am	PRN	Board Changes
8th Sep 2015	7:00 am	PRN	Half-yearly Report
27th Aug 2015	7:00 am	PRN	Notice of Results
7th Jul 2015	4:45 pm	PRN	Director Dealing
17th Jun 2015	5:02 pm	PRN	Director Dealings
12th Jun 2015	7:00 am	PRN	Secondary listing in Germany
11th Jun 2015	1:00 pm	PRN	Result of AGM
11th Jun 2015	7:00 am	PRN	RPL554 Phase 2a trial started
8th Jun 2015	7:00 am	PRN	RPL554 MAD study complete

Latest Share Chat

VRP.L Regulatory News (VRP)

Director Shareholding

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending